Stephen Kirk,
Non-Clinical Immunotoxicologist
Immunology graduate from University of Glasgow. Spent over 3 years in academic research predominantly in the areas of mucosal immunity and lymphocyte trafficking. Since then spent >18 years working in the CRO industry, mostly as a study director, within the field of immunotoxicology. During those years was responsible for the validation and establishment of many immunological assays and techniques as well as the production of numerous presentations. Initially worked at IRI (Edinburgh), before spending 5 years at CTBR (Montreal), returned to the UK in 2005 to take up a position within the toxicology group at Aptuit (Edinburgh), before moving to Covance in 2009. Currently hold the position of pre-clinical immunotoxicology specialist and biologics subject matter expert within the non-clinical safety assessment group at Harrogate. Main responsibilities include designing studies intended to assess preclinical safety of novel biotechnology derived therapies, as well as interpretation of the data generated from such work.
|
|
|
